EUVIMEDEUVIMED entdecken
Crossref

Epstein‐Barr virus‐driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinoma

Feng Shi, Li Shang, Min Zhou, Cong Lv, Yueshuo Li, Cheng Luo, Na Liu, Jingchen Lu, Min Tang, Xiangjian Luo, Jing Xu, Jia Fan und 6 weitere

Journal of Medical Virology · 2024-05 · 96 (5)

DOI: 10.1002/jmv.29634 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 29.04.2024. Verfasst von Feng Shi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Cancer Invasion of Chinese Ministry of Education, XiangYa Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, Virus Activation, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hunan Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic reprogramming induced by Epstein‐Barr virus (EBV) often mirrors metabolic changes observed in cancer cells. Accumulating evidence suggests that lytic reactivation is crucial in EBV‐associated oncogenesis. The aim of this study was to explore the role of metabolite changes in EBV‐associated malignancies and viral life cycle control. We first revealed that EBV (LMP1) accelerates the secretion of the oncometabolite D‐2HG, and serum D‐2HG level is a potential diagnostic biomarker for NPC. EBV (LMP1)‐driven metabolite changes disrupts the homeostasis of global DNA methylation and demethylation, which have a significantly inhibitory effect on active DNA demethylation and 5hmC content. We found that loss of 5hmC indicates a poor prognosis for NPC patients, and that 5hmC modification is a restriction factor of EBV reactivation. We confirmed a novel EBV reactivation inhibitor, α‐KG, which inhibits the expression of EBV lytic genes with CpG‐containing ZREs and the latent‐lytic switch by enhancing 5hmC modification. Our results demonstrate a novel mechanism of which metabolite abnormality driven by EBV controls the viral lytic reactivation through epigenetic modification. This study presents a potential strategy for blocking EBV reactivation, and provides potential targets for the diagnosis and therapy of NPC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 4, HumanVirus ActivationNasopharyngeal CarcinomaNasopharyngeal NeoplasmsEpstein-Barr Virus InfectionsDNA MethylationHumansViral Matrix ProteinsEpigenesis, GeneticDisease Progression

Stichwörter der Autor:innen

5‐hydroxymethylcytosineDNA demethylationD‐2‐hydroxyglutarateEpstein‐Barr virusviral lytic reactivationα‐ketoglutarate

Substanzen

Viral Matrix ProteinsEBV-associated membrane antigen, Epstein-Barr virus

Autor:innen und Institutionen

  • Key Laboratory of Carcinogenesis and Cancer Invasion of Chinese Ministry of Education, XiangYa Hospital, Central South University, Changsha, China.
  • Department of Pathology, National Clinical Research Center for Geriatric Disorders/XiangYa Hospital, Central South University, Changsha, China.
  • Key Laboratory of Carcinogenesis of National Health Commission, Cancer Research Institute and School of Basic Medical Science, Xiangya School of Medicine, Central South University, Changsha, China.
  • State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, China.
  • Department of Radiology, National Clinical Research Center for Geriatric Disorders/XiangYa Hospital, Central South University, Changsha, China.
  • Molecular Imaging Research Center of Central South University, Changsha, China.

ORCID-Profile: Weihua Jia, Ya Cao

Förderung

  • National Natural Science Foundation of China
  • Hunan Provincial Natural Science Foundation of China

Zitieren

APA

Shi, F., Shang, L., Zhou, M., Lv, C., Li, Y., Luo, C., Liu, N., Lu, J., Tang, M., Luo, X., Xu, J., Fan, J., Zhou, J., Gao, Q., Wu, W., Jia, W., Wang, H., & Cao, Y. (2024). Epstein‐Barr virus‐driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinoma. Journal of Medical Virology, 96(5). https://doi.org/10.1002/jmv.29634

Vancouver

Shi F, Shang L, Zhou M, Lv C, Li Y, Luo C, et al. Epstein‐Barr virus‐driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinoma. Journal of Medical Virology. 2024;96(5). doi:10.1002/jmv.29634

BibTeX
@article{Shi2024,
  author = {Shi, Feng and Shang, Li and Zhou, Min and Lv, Cong and Li, Yueshuo and Luo, Cheng and Liu, Na and Lu, Jingchen and Tang, Min and Luo, Xiangjian and Xu, Jing and Fan, Jia and Zhou, Jian and Gao, Qiang and Wu, Weizhong and Jia, Weihua and Wang, Hailin and Cao, Ya},
  title = {Epstein‐Barr virus‐driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinoma},
  journal = {Journal of Medical Virology},
  year = {2024},
  volume = {96},
  number = {5},
  doi = {10.1002/jmv.29634}
}
Kostenlos starten →